Product Information
ABILIFY 2 MG TABLET is a brand product labeled by Otsuka America Pharmaceutical Inc., priced at $18.6528 per EA under NDC 59148000613. Its NADAC has been published 518 times since Nov 28, 2013.
FDA first approved this application on Nov 15, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ARIPIPRAZOLE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Otsuka America Pharmaceutical Inc.NDC
59148000613
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA021436FDA Approved
11/15/2002
TE Code
AB
On Market Since
11/15/2002
Pharmacological Classes
Price Statistics
The NADAC for ABILIFY 2 MG TABLET has been published 518 times since Nov 28, 2013, and over the history we have for it it has declined 14.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.6528 per EA |
|---|---|
| All-time high | $29.1101 (Apr 15, 2015) |
| All-time low | $18.6249 (Dec 17, 2025) |
| 52-week high | $18.6541 |
| 52-week low | $18.6249 |
| Median price | $28.5163 |
| Average price | $25.8598 |
| Largest weekly change | -34.3% (Apr 17, 2024) |
| Weeks tracked | 518 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ABILIFY 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ABILIFY 2 MG TABLET, manufactured by Otsuka America Pharmaceutical Inc., is $18.6528 per EA (NDC 59148000613), effective Aug 19, 2026.
How has the price of ABILIFY 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ABILIFY 2 MG TABLET has declined 14.6%. It has been tracked across 518 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ABILIFY 2 MG TABLET?
Since Nov 28, 2013, the NADAC for ABILIFY 2 MG TABLET has ranged from a low of $18.6249 (Dec 17, 2025) to a high of $29.1101 (Apr 15, 2015), with a median of $28.5163 per EA.
Are there cheaper alternatives to ABILIFY 2 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARIPIPRAZOLE 2 MG TABLET, is $0.1036 per EA — about 99% below ABILIFY 2 MG TABLET.
Who manufactures ABILIFY 2 MG TABLET?
ABILIFY 2 MG TABLET (NDC 59148000613) is labeled by Otsuka America Pharmaceutical Inc., and CMS classifies it as a brand product.